Impact of immunosuppression on coronary endothelial function after cardiac transplantation.

作者: M. Weis , S.M. Wildhirt , C. Schulze , S. Pehlivanli , B.M. Meiser

DOI: 10.1016/S0041-1345(98)00081-5

关键词: ImmunosuppressionVascular diseaseEndotheliumMedicineTacrolimusInternal medicineCardiologyHeart transplantationTransplantationPathologyComplicationAzathioprine

摘要:

参考文章(14)
F M Hofman, M Santucci, S Govindarajan, A Duchini, G Zampi, Effects of tumor necrosis factor-alpha and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells. Journal of Investigative Medicine. ,vol. 44, pp. 474- 482 ,(1996)
Mandeep R Mehra, Hector O Ventura, Suresh P Jain, Keshav Ramireddy, Arshad Ali, Dwight D Stapleton, Frank W Smart, Stephen R Ramee, Tyrone J Collins, Christopher J White, Heterogeneity of Cardiac Allograft Vasculopathy: Clinical Insights From Coronary Angioscopy Journal of the American College of Cardiology. ,vol. 29, pp. 1339- 1344 ,(1997) , 10.1016/S0735-1097(97)00059-4
Clare R. Gregory, Xinfan Huang, Richard E. Pratt, Victor J. Dzau, Randi Shorthouse, Margaret E. Billingham, Randall E. Morris, Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation. ,vol. 59, pp. 655- 661 ,(1995) , 10.1097/00007890-199503150-00002
B.M. Meiser, R.E. Morris, M.E. Billingham, Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. The Lancet. ,vol. 338, pp. 1297- 1298 ,(1991) , 10.1016/0140-6736(91)92594-R
Rajan V. Nair, Randall E. Morris, Immunosuppression in cardiac transplantation: a new era in immunopharmacology. Current Opinion in Cardiology. ,vol. 10, pp. 207- 217 ,(1995) , 10.1097/00001573-199503000-00015
Michael Weis, Wolfgang von Scheidt, None, Cardiac Allograft Vasculopathy A Review Circulation. ,vol. 96, pp. 2069- 2077 ,(1997) , 10.1161/01.CIR.96.6.2069
C. WATSON, S. WHITTAKER, N. SMITH, A. J. VORA, D. C. DUMONDE, K. A. BROWN, IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clinical and Experimental Immunology. ,vol. 105, pp. 112- 119 ,(1996) , 10.1046/J.1365-2249.1996.D01-717.X
Si M. Pham, Robert L. Kormos, Brack G. Hattler, Akihiko Kawai, Athanassios C. Tsamandas, Anthony J. Demetris, Srinivas Murali, Frederick J. Fricker, Huang C. Chang, Ashosk B. Jain, Thomas E. Starzl, Robert L. Hardesty, Bartley P. Griffith, A PROSPECTIVE TRIAL OF TACROLIMUS (FK 506) IN CLINICAL HEART TRANSPLANTATION: INTERMEDIATE-TERM RESULTS The Journal of Thoracic and Cardiovascular Surgery. ,vol. 111, pp. 764- 772 ,(1996) , 10.1016/S0022-5223(96)70336-7
Erik S.G. Stroes, Thomas F. Lüscher, Flip G. de Groot, Hein A. Koomans, Ton J. Rabelink, Cyclosporin A Increases Nitric Oxide Activity In Vivo Hypertension. ,vol. 29, pp. 570- 575 ,(1997) , 10.1161/01.HYP.29.2.570
K. Akita, G. J. Dusting, H. Hickey, Suppression of nitric oxide production by cyclosporin A and FK506A in rat vascular smooth muscle cells. Clinical and Experimental Pharmacology and Physiology. ,vol. 21, pp. 231- 233 ,(1994) , 10.1111/J.1440-1681.1994.TB02503.X